There is one clinical trial.
A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the
glaucoma patients and the normal control will be performed to find genetic marker for primary
open angle glaucoma.
NCT01025024 Conditions
- Single-nucleotide Polymorphism (SNP) for Glaucoma
Interventions
- Genetic: SNP analysis of the DNA
genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns.
Primary Outcomes
Measure: genotyping for the SNP associated with primary open angle glaucoma Time: one year
Secondary Outcomes
Measure: genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns Time: one year